Mereo BioPharma Group plc 20-F for FY2021
Mereo BioPharma Group plc (MREO)
20-F
2022-03-31
For: 2021-12-31
View Original
Added on
April 08, 2026
About this 20-F
Mereo BioPharma Group plc filed this 20-F on March 31, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 36.46M GBP
- Net income
- 12.73M GBP
- compared with a net loss of 163.63M GBP a year earlier
- Diluted EPS
- -0.05 GBP
- compared with -0.48 GBP a year earlier